NORTH HOLLYWOOD, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, has concluded the first-of-its-kind inaugural Myeloma Summit meeting - nearly 70 of the world’s leading experts in myeloma and related blood cancers charting the future of myeloma treatment and care. New drugs that modulate the immune system and target features unique to a myeloma cell have extended remissions for patients while providing a good quality of life. However, the availability of a growing number of options raises questions about when to use which treatments for which patients:
